{"name":"Arsanis, Inc.","slug":"arsanis-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE51R2tXc2U3ajRWc2JmR3IwQmNkUnNJckFrS3B3UXlwLWdvMFZLTkFEc3lIRlNjc0Z1VnJsQVVwLXdmRXE0YTRROFJVNnJrYWNvaF93TlJYclBXcXdubEFZaTZTME5ZbXF6azRwVlM1V3BRZw?oc=5","date":"2024-07-13","type":"pipeline","source":"The Pharma Letter","summary":"X4 Pharmaceuticals | Biotechnology | The Pharmaletter - The Pharma Letter","headline":"X4 Pharmaceuticals | Biotechnology | The Pharmaletter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQZHN6b0NlXy1TdFVoNXQwaDdaUlp1cFE1T0h6OFo5RGRHTjZvUFRCY213OHItNUEwVTJIbFJXRVVOLVY1V1htTlh1UmFmTjZYWXlVRHdKb3VHMG9OSlpwVmUxOWtTUW11TUZpc1FjZ0dOUmNMbGpxU1NTZ01qVk5kYXg4YXc3UlRZcDZha1A4LVBxQldRWEp5QXhON1Z2RFpiTTk2SjhiNFg1MXA3VzgxRjdnMlJsTkgwSFJ5ajZYS1hPUDZ3WDQyeU9B?oc=5","date":"2019-05-22","type":"pipeline","source":"PR Newswire","summary":"Akrevia Therapeutics Appoints René Russo, PharmD, as Chief Executive Officer - PR Newswire","headline":"Akrevia Therapeutics Appoints René Russo, PharmD, as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQanhTV2NBOEFWTFoydWVjOTRmYlktSHFvYWFhRDlQQ0MtczBFV3g0NzFjM1RySVpqcGlYUW53Vm1aVUhFOGtXZDNzYjlrYmctN0hzNXhTXzBUNm5wSERoZFJOTExYY2hsdkVfRzNQMXB5N1Bfa3g3Y0JBNjgtZmYwUEtXMzFzaXZFdllnY05vX3lHTGJkV05hcURVOE1VNTNCVEU4ekFOYWlWQQ?oc=5","date":"2017-12-29","type":"pipeline","source":"The Business Journals","summary":"Twelve Mass. biotech firms raised $1B in IPOs this year. Here they are. - The Business Journals","headline":"Twelve Mass. biotech firms raised $1B in IPOs this year. Here they are.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNNWVuSnVBcjVXMTdxYW1vQ2dlQm4ydGVoVjU1QXVsLXptRDhpN0pYdHFDd2dKazI1OEx5SklZdjlEb3dkYzNJMnFZRXJfWHNWaklIQnVzRGdOYWRXZnpJVFl1LTZ5OE1LTFRTV19XUGFIcjdHZTI1Ym5rNHIwWnYwQ3FLdw?oc=5","date":"2017-12-18","type":"pipeline","source":"BioPharma Dive","summary":"Biotech IPOs show no signs of slowing down in 2018 - BioPharma Dive","headline":"Biotech IPOs show no signs of slowing down in 2018","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}